PGR and breast cancer: Based on the expression level of hormone receptors, such as the estrogen receptor (ER) and progesterone receptor (PR), or human epidermal growth factor receptor (Her2), breast cancers are divided into several subtypes, and small molecules or antibodies targeting ER, PR, and Her2 have been used in breast cancer therapies [2].